Use of Chlamydomonas reinhardtii mutants for anticancer drug screening
Authors:
- Manjul AgarwalMAManjul Agarwal
- Brigitte RenéBRBrigitte René
- Serge FermandjianSFSerge Fermandjian
- 1 October 2002
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 64 (7) , 1125-1131
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The biparental transmission of the mitochondrial genome in Chlamydomonas reinhardtii visualized in living cellsEuropean Journal of Cell Biology, 1998
- Diversity of DNA topoisomerases I and inhibitorsBiochimie, 1998
- Vision in microalgaePlanta, 1997
- Topoisomerase I inhibitors: Review and updateAnnals of Oncology, 1997
- Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agentsMedicinal Research Reviews, 1997
- CHLAMYDOMONAS REINHARDTII AS THE PHOTOSYNTHETIC YEASTAnnual Review of Genetics, 1995
- Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.Proceedings of the National Academy of Sciences, 1995
- The Chlamydomonas FLA10 gene encodes a novel kinesin-homologous protein.Journal of Cell Biology, 1994
- Receptor mediated mineralocorticoid action in alga cell mutantsFEBS Letters, 1992
- Mineralocorticoid hormone action in plant cellsBiochemical and Biophysical Research Communications, 1992